EGFR and metastatic colorectal cancer: During the recent past years, a targeted therapy with monoclonal antibodies (cetuximab and panitumumab), blocking the EGFR-driven cell proliferation signals, has been introduced into the therapy of metastatic colorectal cancer [9,35].